Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Andrzej P. Kudelka

Oncology | Hospital Medicine
1200 N Beaver St, Payer Credentialing, 
Flagstaff, AZ 
Accepting New Patients
Offers Telehealth
43 Years of Experience

Experienced in WT1-Related Wilms Tumor Syndromes
1200 N Beaver St, Payer Credentialing, 
Flagstaff, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Andrzej Kudelka is an Oncologist and a Hospital Medicine provider in Flagstaff, Arizona. Dr. Kudelka has been practicing medicine for over 43 years and is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Breast Cancer, Merkel Cell Carcinoma, Gastric Lymphoma, and Inflammatory Breast Cancer. Dr. Kudelka is currently accepting new patients.

His clinical research consists of co-authoring 6 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
1982
Specialties
Oncology
Hospital Medicine
Licenses
Internal Medicine in NY
Hospital Affiliations
Verde Valley Medical Center
Languages Spoken
English
Polish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

HealthKeepers
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Piedmont
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

1200 N Beaver St, Payer Credentialing, Flagstaff, AZ 86001
Other Locations
6880 W Snowville Rd, Suite 210, Brecksville, OH 44141

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Exemestane, Letrozole, Systemic Chemotherapy
Study Phase: Phase 3
STAMP: Surgically Treated Adjuvant Merkel Cell Carcinoma With Pembrolizumab, a Phase III Trial
STAMP: Surgically Treated Adjuvant Merkel Cell Carcinoma With Pembrolizumab, a Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Procedure, Other, Radiation, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients With High Risk Resected Melanoma
A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients With High Risk Resected Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Procedure, Biological
Study Drugs: Ipilimumab, Pembrolizumab, Recombinant Interferon Alfa-2b
Study Phase: Phase 3
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: September 16, 2025
Intervention Type: Other, Procedure, Biological, Drug
Study Drugs: Dabrafenib Mesylate, Ipilimumab, Nivolumab, Trametinib Dimethyl Sulfoxide
Study Phase: Phase 3
View 3 Less Clinical Trials

6 Total Publications

Ibrutinib-Induced Perianal Rash Complicated by Bacterial Infection in a Patient With Chronic Lymphocytic Leukemia: A Case Report and Literature Review.
Ibrutinib-Induced Perianal Rash Complicated by Bacterial Infection in a Patient With Chronic Lymphocytic Leukemia: A Case Report and Literature Review.
Journal: Cureus
Published: April 24, 2025
View All 6 Publications
Similar Doctors
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Peter J. Mathern
Oncology | Hematology Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Peter J. Mathern
Oncology | Hematology Oncology

Arizona Oncology Associates PC

77 W Forest Ave, Suite 301, 
Flagstaff, AZ 
 (0.1 miles away)
928-635-7307
Languages Spoken:
English, Czech, German, Slovak, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Peter Mathern is an Oncologist and a Hematologist Oncology provider in Flagstaff, Arizona. Dr. Mathern is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Adult Soft Tissue Sarcoma, Paget Disease of the Breast, and Neuroendocrine Tumor. Dr. Mathern is currently accepting new patients.

Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Sarah J. Conlon
Oncology | Hematology
Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Sarah J. Conlon
Oncology | Hematology

Arizona Oncology Associates PC

77 W Forest Ave, Suite 301, 
Flagstaff, AZ 
 (0.1 miles away)
928-635-7307
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sarah Conlon is an Oncologist and a Hematologist in Flagstaff, Arizona. Dr. Conlon is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Conlon is currently accepting new patients.

Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Allan V. Espinosa-Morazan
Oncology | Hematology Oncology
Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Allan V. Espinosa-Morazan
Oncology | Hematology Oncology

Arizona Oncology Associates PC

3188 N Windsong Dr A, 
Prescott Valley, AZ 
 (55.0 miles away)
928-775-9430
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Allan Espinosa-Morazan is an Oncologist and a Hematologist Oncology provider in Prescott Valley, Arizona. Dr. Espinosa-Morazan is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer. Dr. Espinosa-Morazan is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kudelka's expertise for a condition
ConditionClose
      • Advanced
      • ALK-Positive Non-Small Cell Lung Cancer
        Dr. Kudelka is
        Advanced
        . Learn about ALK-Positive Non-Small Cell Lung Cancer.
        See more ALK-Positive Non-Small Cell Lung Cancer experts
      • Breast Cancer
        Dr. Kudelka is
        Advanced
        . Learn about Breast Cancer.
        See more Breast Cancer experts
      • Colorectal Cancer
        Dr. Kudelka is
        Advanced
        . Learn about Colorectal Cancer.
        See more Colorectal Cancer experts
      • EGFR Positive Lung Cancer
        Dr. Kudelka is
        Advanced
        . Learn about EGFR Positive Lung Cancer.
        See more EGFR Positive Lung Cancer experts
      • Familial Colorectal Cancer
        Dr. Kudelka is
        Advanced
        . Learn about Familial Colorectal Cancer.
        See more Familial Colorectal Cancer experts
      • Febrile Neutropenia
        Dr. Kudelka is
        Advanced
        . Learn about Febrile Neutropenia.
        See more Febrile Neutropenia experts
      View All 21 Advanced Conditions
      • Experienced
      • Acute Myeloblastic Leukemia with Maturation
        Dr. Kudelka is
        Experienced
        . Learn about Acute Myeloblastic Leukemia with Maturation.
        See more Acute Myeloblastic Leukemia with Maturation experts
      • Acute Myeloblastic Leukemia without Maturation
        Dr. Kudelka is
        Experienced
        . Learn about Acute Myeloblastic Leukemia without Maturation.
        See more Acute Myeloblastic Leukemia without Maturation experts
      • Acute Myeloid Leukemia (AML)
        Dr. Kudelka is
        Experienced
        . Learn about Acute Myeloid Leukemia (AML).
        See more Acute Myeloid Leukemia (AML) experts
      • Adrenal Cancer
        Dr. Kudelka is
        Experienced
        . Learn about Adrenal Cancer.
        See more Adrenal Cancer experts
      • Adult Soft Tissue Sarcoma
        Dr. Kudelka is
        Experienced
        . Learn about Adult Soft Tissue Sarcoma.
        See more Adult Soft Tissue Sarcoma experts
      • Agranulocytosis
        Dr. Kudelka is
        Experienced
        . Learn about Agranulocytosis.
        See more Agranulocytosis experts
      View All 111 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2025 All Rights Reserved